TRPC3
Basic information
Region (hg38): 4:121874481-121952060
Links
Phenotypes
GenCC
Source:
- spinocerebellar ataxia type 41 (Supportive), mode of inheritance: AD
- spinocerebellar ataxia type 41 (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spinocerebellar ataxia 41 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 25477146 |
ClinVar
This is a list of variants' phenotypes submitted to
- Spinocerebellar ataxia type 41 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRPC3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 37 | 46 | ||||
missense | 70 | 72 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 14 | 19 | ||||
Total | 1 | 0 | 75 | 51 | 15 |
Variants in TRPC3
This is a list of pathogenic ClinVar variants found in the TRPC3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-121879758-G-A | Uncertain significance (Dec 19, 2023) | |||
4-121879767-T-G | Benign (Aug 16, 2023) | |||
4-121879801-C-T | not specified | Uncertain significance (Jan 24, 2023) | ||
4-121879811-T-A | Uncertain significance (Oct 13, 2022) | |||
4-121879816-T-C | Benign (Jan 29, 2024) | |||
4-121879818-T-C | not specified | Uncertain significance (Jun 09, 2022) | ||
4-121879822-C-T | not specified | Uncertain significance (Aug 11, 2022) | ||
4-121879832-T-C | Benign (Jan 22, 2024) | |||
4-121879894-T-TA | Benign (Jan 15, 2024) | |||
4-121882357-C-A | Uncertain significance (Jul 01, 2017) | |||
4-121882367-A-C | not specified | Uncertain significance (Oct 09, 2024) | ||
4-121882400-A-G | Likely benign (Apr 01, 2022) | |||
4-121899594-C-T | Likely benign (Sep 07, 2022) | |||
4-121899595-G-A | Likely benign (May 23, 2023) | |||
4-121899614-G-T | Spinocerebellar ataxia type 41 | Uncertain significance (-) | ||
4-121899620-G-A | Uncertain significance (Feb 04, 2023) | |||
4-121899678-C-T | Likely benign (Aug 17, 2022) | |||
4-121899690-G-A | TRPC3-related disorder | Likely benign (May 29, 2023) | ||
4-121899691-T-G | Uncertain significance (Jun 22, 2023) | |||
4-121899709-C-T | Likely benign (Aug 10, 2023) | |||
4-121902842-C-T | Likely benign (Jun 09, 2023) | |||
4-121902843-G-A | Likely benign (Oct 17, 2023) | |||
4-121902856-G-A | Uncertain significance (Apr 06, 2022) | |||
4-121902868-C-T | not specified | Uncertain significance (Apr 11, 2023) | ||
4-121902877-A-G | Uncertain significance (Apr 09, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRPC3 | protein_coding | protein_coding | ENST00000379645 | 12 | 72728 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.08e-7 | 0.999 | 125691 | 0 | 57 | 125748 | 0.000227 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.84 | 267 | 512 | 0.522 | 0.0000303 | 6053 |
Missense in Polyphen | 69 | 188.07 | 0.36689 | 2048 | ||
Synonymous | 1.37 | 180 | 205 | 0.878 | 0.0000138 | 1758 |
Loss of Function | 3.01 | 18 | 38.0 | 0.473 | 0.00000196 | 470 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000486 | 0.000483 |
Ashkenazi Jewish | 0.000102 | 0.0000992 |
East Asian | 0.00126 | 0.00125 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.00126 | 0.00125 |
South Asian | 0.0000981 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Thought to form a receptor-activated non-selective calcium permeant cation channel. Probably is operated by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases or G-protein coupled receptors. Activated by diacylglycerol (DAG) in a membrane-delimited fashion, independently of protein kinase C, and by inositol 1,4,5- triphosphate receptors (ITPR) with bound IP3. May also be activated by internal calcium store depletion. {ECO:0000269|PubMed:20095964, ECO:0000269|PubMed:8646775, ECO:0000269|PubMed:9417057, ECO:0000269|PubMed:9930701}.;
- Pathway
- Axon guidance - Homo sapiens (human);BDNF-TrkB Signaling;Signaling by GPCR;Signal Transduction;ion channels and their functional role in vascular endothelium;Stimuli-sensing channels;Ion channel transport;Transport of small molecules;Effects of PIP2 hydrolysis;Platelet activation, signaling and aggregation;Hemostasis;TRP channels;Elevation of cytosolic Ca2+ levels;Platelet calcium homeostasis;Platelet homeostasis;G alpha (q) signalling events;GPCR downstream signalling;Trk receptor signaling mediated by PI3K and PLC-gamma
(Consensus)
Recessive Scores
- pRec
- 0.246
Intolerance Scores
- loftool
- 0.195
- rvis_EVS
- -1.24
- rvis_percentile_EVS
- 5.41
Haploinsufficiency Scores
- pHI
- 0.349
- hipred
- Y
- hipred_score
- 0.737
- ghis
- 0.589
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.762
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trpc3
- Phenotype
- growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- calcium ion transport;manganese ion transport;single fertilization;phototransduction;positive regulation of calcium ion transport into cytosol;platelet activation;response to ATP;regulation of cytosolic calcium ion concentration;response to calcium ion;calcium ion transmembrane transport;positive regulation of cardiac muscle hypertrophy in response to stress
- Cellular component
- plasma membrane;integral component of plasma membrane;cation channel complex
- Molecular function
- calcium channel activity;protein binding;store-operated calcium channel activity;inositol 1,4,5 trisphosphate binding